ArticleFrontiers in public health2025
Temporal trends in prevalence and years of life lived with disability for hearing loss in China from 1990 to 2021: an analysis of the global burden of disease study 2021.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Connexin 26 in Hearing Health and Disease: StructuralFoundations, Mutation Mechanisms, and Therapeutic Perspectives.International journal of molecular sciences · 2026Review
- Prevalence and sex differences in moderate-to-severe hearing loss among older adults: a cross-sectional study.BMC geriatrics · 2026Article
- Global, regional, and national burden of hearing loss from 1990 to 2021: findings from the 2021 global burden of disease study.Annals of medicine · 2025Article
- Global temporal trends and projections of epilepsy in women of childbearing age: insights from the global burden of disease study 2021.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025Article
- Cochlear Implants and Adult Patient Experiences, Adaptation and Challenges: A Survey.Audiology research · 2025Article
- Temporal trends and future projections of cysticercosis-induced epilepsy: insights from the global burden of disease study 2021- a cross-sectional study.Frontiers in public health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hearing loss (HL) poses a serious threat to the health and quality of life of Chinese population. This study analyzes the burden of HL in China from 1990 to 2021 and projects future trends in next 15 years. Methods: Data derived from the Global Burden of Disease (GBD) 2021 study were utilized. The join-point regression model was employed to calculate the average annual percentage change (AAPC) in the prevalence and years of life lived with disability (YLDs) of HL. Age-period-cohort analysis was conducted to assess age, period and cohort effects. Decomposition analysis was performed to analyze the impacts of aging, population and epidemiological change. ARIMA model was utilized for forecasting the burden of HL from 2022 to 2036. Results: From 1990 to 2021, the number of prevalence and YLDs of HL in China rose by 125.06 and 135.13%, with an average annual percentage change of 0.19 and 0.28% for age-standardized rate (ASR) of prevalence and YLDs, respectively. Age-period-cohort analysis indicated that the risks associated with ASR of prevalence and YLDs for HL increased with age. The period effects on the ASRs of prevalence and YLDs were generally increasing (relative risk [RR] 0.98-1.06 and 0.96-1.05). Cohort effects on the risk also rising (RR 0.90-1.41 and 0.83-1.26). Aging growth accounted for the largest proportion of the increase of the number of prevalence and YLDs (68.62 and 66.39%, respectively). The prevalence and YLDs rates are expected to stabilize from 2022 to 2036, while the age-standardized prevalence rate remains above 20%. The number of people suffering from HL will reach 573.8 million, while the number of YLDs will reach 16 million. Conclusion: The prevalent cases of HL have risen dramatically in China over the past 32 years, which expected to continue to grow by 2036, additional interventions such as enhancing primary hearing care services and boosting screening rates for HL are essential to alleviate the burden of HL, especially in the older adult population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.